C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 417/12 (2006.01) A61K 31/4439 (2006.01) A61P 3/00 (2006.01)
Patent
CA 2644166
The invention relates to use of A1 and/or dual A1/A2b agonists of formula (IA) and (IB) for production of a medicament for treatment of dyslipidemia, metabolic syndrome and diabetes and dyslipidemia, metabolic syndrome and diabetes in connection with hypertonia and diseases of the cardiovascular system.
La présente invention concerne l'utilisation d'agonistes A1 et/ou d'agonistes mixtes A1/A2b représentés par les formules (IA) et (IB) pour produire un médicament destiné au traitement de la dyslipidémie, du syndrome métabolique et du diabète ainsi que de la dyslipidémie, du syndrome métabolique et du diabète liés à l'hypertonie et de maladies du système cardiovasculaire.
Albrecht-Kuepper Barbara
Bischoff Hilmar
Diedrichs Nicole
Huebsch Walter
Krahn Thomas
Bayer Healthcare Ag
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Use of adenosine a1 and/or dual a1/a2b agonists for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of adenosine a1 and/or dual a1/a2b agonists for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of adenosine a1 and/or dual a1/a2b agonists for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1943583